role in hardening of arteries
A protein that was previously thought to prevent hardening of the arteries has been shown to actually cause the disease, according to a Yale study.
Interferon-gamma, a key immune factor protein produced by certain white blood cells, was thought to inhibit processes responsible for hardening of the arteries, or arteriosclerosis. But in a study published Jan. 13 in Nature, Yale researchers report that interferon-gamma causes arteriosclerosis in an animal model consisting of different species.
"We've found that interferon-gamma causes muscle cells within the artery wall to multiply and form lesions which can obstruct the flow of blood," says George Tellides, assistant professor of cardiothoracic surgery at the School of Medicine. "This observation may improve our ability to develop treatments for arteriosclerosis, which can result in devastating complications such as heart attacks, strokes and gangrene."
Arteriosclerosis occurs when an increased number of muscle cells within parts of blood vessels contribute to hardening of the arteries. It is considered an immunological disease resulting from the interactions of white blood cells with the cells of the artery wall. The disease occurs most often in individuals with risk factors of smoking, high blood pressure, high cholesterol and diabetes; it may also occur in an accelerated fashion in the transplanted hearts of organ recipients.
In the study, researchers inserted segments of arteries from pig or human hearts into the major blood vessels of mice that lack immune systems. The mice cannot reject the foreign arteries because they are deficient in white blood cells. The mice were then treated with injections of pig or human interferon-gamma for one month, resulting in an abnormal thickening of the transplanted arteries. The arteriosclerotic lesions, consisting of large numbers of muscle cells, occurred in the absence of white blood cells -- which, if present, could have confounded the interpretation of the results. Therefore, the results support the idea that arteriosclerosis is an immunological disease, says Tellides.
"From this study, we may identify methods to genetically alter pigs to serve as organ donors of hearts resistant to arteriosclerosis," says Tellides. "The 'humanized mouse' model provides a unique system to test these strategies prior to clinical application."
The study was part of a novel interdepartmental research program at the medical school, which allows diverse experts, such as heart surgeons and molecular biologists, to work together. Collaborators at Yale included Dennis A. Tereb, Nancy C. Kirkles-Smith, Richard W. Kim, Jean H. Wilson, Jeffrey S. Schechner, Marc I. Lorber and Jordan S. Pober.
-- By Karen Peart
T H I S
Bulletin Home
W E E K ' SS T O R I E S
Gift honors Zigler for work shaping nation's policies on children's issues
Study shows welfare reform adversely impacts children
Grant supports publication of the papers of James Boswell
Beinecke show traces Americans' utopian visions
MEDICAL SCHOOL NEWS
Scholar Gates recalls Yale days in campus talks
Discovery involving cell proteins results in 'paradigm shift'
Founders of American hospice will be honored at convocation
Paul Fry reappointed as college's master
Experts to discuss potential effects of global climate change
TIAA-CREF cites economist's work on Social Security
Multifaceted flautist to perform his own compositions
Yale Scoreboard
Former Big 10 coach honored by Camp Foundation
Concert features School of Music professor, student
Historian to hold booksigning
. . . In the News . . .|Visiting on Campus|
Calendar of Events|Bulletin Board
Classified Ads|Search Archives|Production Schedule|Bulletin Staff
Public Affairs Home|News Releases|
E-Mail Us|Yale Home Page